Kirkland & Ellis and Milbank have advised on the €2.4 billion sale of French biopharma supplier Polyplus to life science group Sartorius.
The Kirkland team, led by London corporate partner Adrian Maguire and Paris partner Laurent Victor-Michel, advised Polyplus’ sellers, private investors Archimed and a Warburg Pincus affiliate. The team included London debt finance partner Stefan Arnold-Soulby; Washington, D.C., antitrust partner Marin Boney and London partner Matthew Sinclair-Thomson; and London tax partner Peter Abbott and Paris partner Sonia Bouaffassa.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
